Systemic levels of matrix metalloproteinase-9 in patients with multiple myeloma may be useful as a prognostic index of bone disease. Reply to the Letter by Demacq and Montenegro
Sfiridaki, Aikaterini, Miyakis, Spiros, Tsirakis, George, Alegakis, Athanassios, Passam, Andreas M., Kandidaki, Ermioni, Margioris, Andrew N., Alexandrakis, Michael G.Volume:
44
Language:
english
Journal:
Clinical Chemical Laboratory Medicine
DOI:
10.1515/cclm.2006.044
Date:
January, 2006
File:
PDF, 30 KB
english, 2006